Chargement en cours...
Management of the pregnant inflammatory bowel disease patient on antitumour necrosis factor therapy: State of the art and future directions
Antitumour necrosis factor (anti-TNF) therapy has been a major advance in the treatment of inflammatory bowel disease (IBD) by improving rates of mucosal healing, steroid-free remission, and decreasing rates of hospitalization and surgery. Because IBD affects women in their reproductive years, clini...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Pulsus Group Inc
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4205908/ https://ncbi.nlm.nih.gov/pubmed/25101334 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|